aristolochic acid i has been researched along with transforming growth factor beta in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, SQ; Li, B; Li, XM; Wang, X; Zhang, CY | 1 |
| Chen, YP; Fang, J; Yang, YF; Zhang, W | 1 |
| Bourgeade, MF; Decaestecker, C; Deschodt-Lanckman, MM; Husson, CP; Nortier, JL; Pozdzik, AA; Rogier, E; Salmon, IJ; Vanherweghem, JL | 1 |
| Kamijo-Ikemorif, A; Kimura, K; Matsui, K; Sugaya, T; Yasuda, T | 1 |
| Duffield, JS; Kannan, K; Li, S; Mariappan, N; Megyesi, J; Portilla, D; Price, PM; Shank, B; Theus, S | 1 |
| Gao, L; Peng, X; Tian, Y; Wu, G; Yang, Y; Zhang, Z; Zhao, H | 1 |
| Antoine, MH; Bourgeade, MF; De Prez, E; Debelle, F; Declèves, AE; El Kaddouri, F; Husson, C; Mies, F; Nortier, JL; Piccirilli, J | 1 |
| Alford, C; Fogo, AB; Gewin, L; Hao, CM; Harris, RC; Neelisetty, S; Nlandu-Khodo, S; Reynolds, K; Woodbury, L; Yang, H; Zent, R | 1 |
| Bai, X; Cheng, XL; Lin, RC; Vaziri, ND; Wang, HL; Wei, F; Zhao, YY | 1 |
| Li, J; Li, Y; Mao, Y; Peng, X; Yu, F; Zhang, M; Zhang, X | 1 |
| Chang, JF; Chen, YW; Hsieh, CY; Hung, CF; Liang, SS; Lin, CC; Liou, JC; Lu, KC; Wu, MS | 1 |
| Abe, E; Atobe, Y; Azushima, K; Funakoshi, K; Kanaoka, T; Kinguchi, S; Suzuki, T; Taguchi, S; Tamura, K; Tanaka, S; Tsukamoto, S; Uneda, K; Urate, S; Wakui, H; Yamaji, T; Yamashita, A | 1 |
| Chen, S; Cheng, Z; Li, C; Li, D; Li, H; Liu, P; Ma, Y; Peng, J; Shao, W; Shen, X; Yin, S; You, Y; Yu, Y; Zhou, C | 1 |
| Bu, XZ; Chen, L; Li, W; Lou, LL; Tang, GH; Weng, HZ; Yin, S; Zhou, BH; Zou, YH | 1 |
14 other study(ies) available for aristolochic acid i and transforming growth factor beta
| Article | Year |
|---|---|
[Cellular mechanism of renal proximal tubular epithelial cell injury induced by aristolochic acid I and aristololactam I].
Topics: Apoptosis; Aristolochic Acids; Cell Line; Epithelial Cells; Fibronectins; Humans; Kidney Tubules, Proximal; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
[Antagonistic effect of yishen ruanjian san contained serum against aristolochic acid in antagonizing human renal interstitial fibroblasts].
Topics: Animals; Aristolochic Acids; Cells, Cultured; Drugs, Chinese Herbal; Extracellular Matrix; Fibroblasts; Kidney; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serum; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy.
Topics: Animals; Aristolochic Acids; Disease Models, Animal; Fibrosis; Kidney; Kidney Failure, Chronic; Macrophages; Male; Monocytes; Rats; Rats, Wistar; Signal Transduction; Smad2 Protein; Smad3 Protein; T-Lymphocytes; Transforming Growth Factor beta | 2008 |
Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
Topics: Acute Kidney Injury; Animals; Aquaporin 1; Aristolochic Acids; Body Weight; Chemokine CCL2; Fatty Acid-Binding Proteins; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kidney; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oxidative Stress; Procollagen; Transforming Growth Factor beta | 2011 |
Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.
Topics: Animals; Arginase; Aristolochic Acids; B7-2 Antigen; Collagen Type I; Collagen Type IV; Down-Regulation; Fibrosis; Interleukin-10; Kidney Diseases; Kidney Tubules, Proximal; Laminin; Mice; Mice, Transgenic; MicroRNAs; Nephritis; PPAR alpha; Transforming Growth Factor beta; Ureteral Obstruction | 2013 |
Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models.
Topics: Actins; Animals; Aristolochic Acids; Dose-Response Relationship, Drug; E1A-Associated p300 Protein; Gene Expression Regulation; Histone Deacetylase 1; Kidney; Kidney Diseases; Mice; RNA, Messenger; Smad Proteins; Specific Pathogen-Free Organisms; Transforming Growth Factor beta | 2014 |
Human bone morphogenetic protein-7 does not counteract aristolochic acid-induced renal toxicity.
Topics: Animals; Aristolochic Acids; beta Catenin; Bone Morphogenetic Protein 7; Cell Line; Fibronectins; Fibrosis; Humans; Kidney; Male; Rats, Wistar; Recombinant Proteins; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Treatment Outcome; Vimentin | 2015 |
Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.
Topics: Actins; Animals; Aristolochic Acids; Cells, Cultured; Collagen Type I; Disease Models, Animal; Extracellular Matrix; Fibrosis; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; Protein Serine-Threonine Kinases; Receptor, Platelet-Derived Growth Factor beta; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Time Factors; Transforming Growth Factor beta; Ureteral Obstruction | 2015 |
Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy.
Topics: Animals; Aristolochic Acids; Disease Models, Animal; Fibrosis; Inflammation; Kidney; Lipids; Male; Metabolomics; Nephritis, Interstitial; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Triglycerides | 2015 |
The potential role of aquaporin 1 on aristolochic acid I induced epithelial mesenchymal transition on HK-2 cells.
Topics: Aquaporin 1; Aristolochic Acids; Cell Line; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Humans; Kidney Diseases; Kidney Tubules; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2018 |
Therapeutic Targeting of Aristolochic Acid Induced Uremic Toxin Retention, SMAD 2/3 and JNK/ERK Pathways in Tubulointerstitial Fibrosis: Nephroprotective Role of Propolis in Chronic Kidney Disease.
Topics: Animals; Aristolochic Acids; Cresols; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Indican; JNK Mitogen-Activated Protein Kinases; Kidney Tubules; Mice, Inbred C57BL; Propolis; Renal Insufficiency, Chronic; Signal Transduction; Smad2 Protein; Smad3 Protein; Sulfuric Acid Esters; Transforming Growth Factor beta; Uremia | 2020 |
Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice.
Topics: Aging; Animals; Aristolochic Acids; beta-Galactosidase; Collagen; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Humans; Kidney; Klotho Proteins; Male; Mice; Mice, Inbred C57BL; Mitochondria; Nephritis, Interstitial; Reactive Oxygen Species; Renal Insufficiency, Chronic; Signal Transduction; Transforming Growth Factor beta | 2021 |
Inhibitory effect of ethyl acetate extract of Aristolochia yunnanensis on cardiac fibrosis through extracellular signal-regulated kinases 1/2 and transforming growth factor β/small mother against decapentaplegic signaling pathways.
Topics: Acetates; Animals; Aristolochia; Fibrosis; Heart Diseases; MAP Kinase Signaling System; Plant Extracts; Rats; Signal Transduction; Transforming Growth Factor beta | 2014 |
(+)-Isobicyclogermacrenal and spathulenol from Aristolochia yunnanensis alleviate cardiac fibrosis by inhibiting transforming growth factor β/small mother against decapentaplegic signaling pathway.
Topics: Aldehydes; Animals; Aristolochia; Fibrosis; Humans; Male; Medicine, Chinese Traditional; Mice; Mothers; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; Transforming Growth Factor beta | 2019 |